Press Releases

Date	Title and Summary	View
Apr 13, 2021	PerkinElmer Provides First Quarter Update and Schedules Earnings Call for Tuesday, May 4, 2021
Apr 1, 2021	EUROIMMUN Launches SARS-CoV-2 NeutraLISA Assay to Determine the Neutralizing Capacity of Anti-SARS-CoV-2 Antibodies
Mar 29, 2021	Horizon Discovery Extends Gene Modulation Portfolio with Industry First Synthetic Single Guide RNA and Patent Pending dCas9 Repressor for CRISPR Interference
Mar 18, 2021	PerkinElmer Launches Industry-First CRM Reagent and Consumable Kit to Streamline Cannabis Pesticide Testing Workflows
Mar 17, 2021	PerkinElmer Further Expands Industry-Leading Signals™ Informatics Capabilities in Biologics Drug Discovery
Mar 16, 2021	EUROIMMUN Launches Novel Ultrafast Automated Microscope and Intelligent Software for State-of-the-Art Diagnostics
Mar 9, 2021	PerkinElmer Completes Acquisition of Oxford Immunotec Global PLC
Mar 9, 2021	PerkinElmer Launches Comprehensive Solutions for Detecting SARS-CoV-2 Mutations
Mar 8, 2021	PerkinElmer Adds HPLC Columns to Consumables Portfolio
Mar 4, 2021	PerkinElmer Prices Offering of Senior Notes